Renaissance Technologies - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,698
-43.3%
116,562
-35.8%
0.00%
-42.9%
Q4 2022$4,760
-99.9%
181,662
-17.2%
0.01%
+16.7%
Q3 2022$4,312,000
-9.7%
219,342
-19.6%
0.01%0.0%
Q2 2022$4,774,000
+9.4%
272,962
+2.3%
0.01%
+20.0%
Q1 2022$4,364,000
-27.4%
266,742
-27.6%
0.01%
-28.6%
Q4 2021$6,013,000
-11.4%
368,642
-30.6%
0.01%
-22.2%
Q3 2021$6,783,000
-25.5%
531,562
-17.6%
0.01%
-18.2%
Q2 2021$9,109,000
-21.0%
645,142
-13.0%
0.01%
-21.4%
Q1 2021$11,528,000
-13.1%
741,842
-11.3%
0.01%0.0%
Q4 2020$13,260,000836,0860.01%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 5,161,888$135,241,46629.11%
Octagon Capital Advisors LP 2,551,703$66,854,61910.41%
Affinity Asset Advisors, LLC 818,035$21,432,5178.40%
Frazier Life Sciences Management, L.P. 4,345,559$113,853,6467.08%
Saturn V Capital Management LP 423,177$6,728,2985.58%
Altium Capital Management LP 385,000$10,087,0005.13%
Deep Track Capital, LP 3,000,000$78,600,0003.30%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 340,389$8,914,7882.75%
Vivo Capital, LLC 872,151$22,8502.63%
Nan Fung Group Holdings Ltd 113,950$2,985,4902.06%
View complete list of CHINOOK THERAPEUTICS INC shareholders